<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">150</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>ALVEOLAR CLEFTS REPAIR USING AUTOGENOUS BONE MARROW DERIVED MESENCHYMAL STEM CELLS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Khalifa</surname><given-names>Mahmoud E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nowair</surname><given-names>Ibrahim M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Ibrahim</surname><given-names>Marwa T.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Arafa</surname><given-names>Enas</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>30</day><month>01</month><year>2016</year></pub-date><volume/><issue/><fpage>10</fpage><lpage>14</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Background: Secondary alveolar bone grafting of the cleft alveolar ridge in the mixed dentition is a well-established treatment for patients with cleft lip and palate (CLP). Recently tissue engineering has become available as a regenerative treatment for bone defects; however little has been reported on application of tissue engineering for regeneration of cleft defect tissues. Mesmesenchymal derived stem cells were applied to different kinds of bone substitute in attempt to overcome the drawbacks of bone grafting. Materials and methods: Eight patients with alveolar cleft were included in this study; the cleft repair was done using bone marrow derived stem cell loaded on NanoBone__ampersandsignreg; scaffold. All patients were followed up clinically and radiographically for 6 months postoperatively. Results: The successful healing was observed without oronasal fistula. In all patients the closure of the alveolar arch and stabilization of the teeth adjacent to the cleft were achieved. The radio-opacity in serial computed tomography slicing the middle level of the alveolar cleft in the grafted region increased gradually over the time. Conclusion: Tissue engineered bone from mesenchymal stem cells may provide an acceptable alternative especially in the case of limited autograft availability or donor site morbidity&#13;
</p></abstract><kwd-group><kwd>Alveolar cleft</kwd><kwd> Stem cell</kwd><kwd> Tissue engineering</kwd></kwd-group></article-meta></front></article>
